Sign In / Register
Make This My Home Page | Feedback |RSS
You are here: IE »   Story

HCL to go ahead with Axon bid as Infy bows out

  • Print
  • Mail This Article
  • Comments
  • Add to favorites
  • Hours after Infosys announced its decision not to raise its bid for Axon, HCL Technologies today said it has decided to go ahead with its proposal for acquiring the UK-based consultancy major, valued at £441.1 million. HCL, through its subsidiary of HCL EAS, has already bought 0.47 per cent equity of Axon.

    “With the consent of the UK Takeover Panel and Axon, HCL has decided to implement the offer by way of a scheme of arrangement. The acquisition continues to be on the same terms and conditions as set out in the original announcement of September 26,” the company said.

    It is anticipated that Axon would post the Scheme Document to Axon Shareholders on or around October 24, with completion of the deal expected prior to the end of the year. On September 26, the board of HCL announced the terms of a cash offer to acquire the entire issue and to be issued share capital of Axon Group Plc at a price of 650 pence in cash per Axon share, valuing the entire issued and to be issued share capital of Axon at approximately £441.1 million.

    Ads by Google

    Comments
    Post comment

    Be the first to comment.

    Post a Comment
    Name:
    Email:
    Title:
    Maximum characters allowed     
    Comment:
    TERMS OF USE:
    The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
    I agree to the terms of use.